Tomer Berkovitz

Dr. Berkovitz serves on the Board of Directors for PrognomiQ. He is also Partner and CFO at aMoon Fund, a leading global HealthTech & Life Sciences venture capital fund, with over $1 billion under management. Prior to joining aMoon in 2018, he was COO and CFO for Alcobra, a NASDAQ-traded pharmaceutical company that merged with Arcturus Therapeutics. Prior to Alcobra, Mr. Berkovitz was at JP Morgan in their Investment Banking division in New York. He currently serves on the Board of several private healthcare companies. Mr. Berkovitz received his Ph.D. in Finance from Columbia Business School.